Vektor Medical Secures $16 Million Series A Funding
PRIVATEFeb 05, 2024
Amount Raised
$16 Million
Round Type
Series A
San DiegoBiotechnologyHealthcareHealth CareArtificial IntelligenceMedicalMachine LearningHealth Diagnostics
Investors
Tvm Capital Life ScienceSolas Bio Ventures
Description
Vektor Medical secured $16 million in Series A funding co-led by Solas BioVentures and TVM Capital Life Science. The funding will support the commercialization of vMap®, Vektor’s AI-based arrhythmia analysis tool, and the expansion of clinical support and additional clinical studies.
Company Information
Company
Vektor Medical
Location
San Diego, California, United States
About
Vektor Medical is a pioneer in non-invasive, AI-based arrhythmia analysis technology, aiming to revolutionize arrhythmia care for millions affected by atrial fibrillation and other arrhythmias. Their flagship product, vMap, is an AI-based, non-invasive arrhythmia analysis tool designed to improve cardiac ablation outcomes, optimize workflows, and increase procedural efficiency.
Fundz sees it the moment Vektor Medical raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
San DiegoBiotechnologyHealthcareHealth CareArtificial IntelligenceMedicalMachine LearningHealth Diagnostics